Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 282
Titolo Data di pubblicazione Autori File
Inhibitors of tumor angiogenesis 1-gen-2008 GENERALI, DANIELE +
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: A rhythmometric analysis 1-gen-2008 GENERALI, DANIELE +
Down-regulation of phosphatidylinositol 3́-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer 1-gen-2008 GENERALI, DANIELE +
Dealing with Down syndrome occurrence risk 1-gen-2009 GENERALI, DANIELE +
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients 1-gen-2009 GENERALI, DANIELE +
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines 1-gen-2009 GENERALI, DANIELE +
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib 1-gen-2009 GENERALI, DANIELE +
Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer 1-gen-2009 GENERALI, DANIELE +
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 1-gen-2010 GENERALI, DANIELE +
Synergistic activity of letrozole and sorafenib on breast cancer cells 1-gen-2010 GENERALI, DANIELE +
Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancer 1-gen-2011 GENERALI, DANIELE +
"Overcoming breast cancer drug resistance with mTOR inhibitors". Could it be a myth or a real possibility in the short-term future? 1-gen-2011 GENERALI, DANIELE +
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen 1-gen-2011 GENERALI, DANIELE +
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: A phase III, randomized, open-label trial 1-gen-2011 GENERALI, DANIELE +
New omics information for clinical trial utility in the primary setting 1-gen-2011 GENERALI, DANIELE +
The 4th International Consensus Conference: Primary Systemic Treatment in the Management of Operable Breast Cancer: Toward the Rapid Assessment of Therapy Efficacy, 2010, Cremona, Italy 1-gen-2011 GENERALI, DANIELE +
Positron emission tomography and neoadjuvant therapy of breast cancer 1-gen-2011 GENERALI, DANIELE +
Use of metronomic chemotherapy in oncology: Results from a national Italian survey 1-gen-2011 SEBASTIANI, FEDERICAGENERALI, DANIELE +
Molecular oncology and the neoadjuvant setting: The perfect blend for treatment personalization and clinical trial design 1-gen-2011 GENERALI, DANIELE +
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the fourth symposium on primary systemic therapy in the management of operable breast cancer, Cremona, Italy (2010) 1-gen-2011 GENERALI, DANIELETAGLIABUE, ELDA +
Mostrati risultati da 21 a 40 di 282
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile